1. CD44 variant 6 is associated with prostate cancer growth and chemo-/radiotherapy response in vivo
   Jie Ni et al, 2020, Experimental Cell Research CrossRef
2. Overexpression of Specific CD44 Isoforms Is Associated with Aggressive Cell Features in Acquired Endocrine Resistance
   Rebecca Bellerby et al, 2016, Frontiers in Oncology CrossRef